Melanoma Diagnoses Set to Rise 10.6% in 2026 — Where McKee's Pathology of the Skin Fits In
The American Cancer Society's Cancer Facts & Figures 2026 report, updated by the Skin Cancer Foundation in January, projects melanoma diagnoses will rise 10.6% this year, to an estimated 234,680 cases — 112,000 of them invasive. Mortality keeps falling thanks to systemic therapy advances, but that only raises the stakes on the diagnostic side: more biopsies, more borderline lesions, and more pressure on the pathologist reading the slide to get the call right the first time.
That's exactly the gap McKee's Pathology of the Skin with Clinical Correlations, 6th Edition (Calonje, Brenn, Lazar & Billings, Elsevier) is built to close. This two-volume reference pairs more than 5,000 histopathologic and clinical illustrations with an extensively revised melanoma chapter reflecting current molecular mechanisms and targeted-therapy implications — the same territory driving this year's diagnostic volume.
Three places it earns its shelf space immediately:
- Melanocytic lesion work-up: differential-diagnosis tables and clinical correlation for distinguishing melanoma from its many histologic mimics, the exact judgment call behind the "too much screening, not enough certainty" problem researchers flagged this year.
- Molecular and staging context: updated coverage of next-generation sequencing and new antigens/antibodies for tumor diagnosis, relevant wherever gene-expression profiling is now feeding into staging decisions alongside AJCC8.
- Teaching and sign-out: bulleted clinical-feature lists built for the bench, making it as useful for a pathology resident building pattern recognition as for the attending signing out a difficult case.
For academic medical libraries, McKee's has been the standard dermatopathology reference across five editions — the natural core-collection pairing for programs that already hold general surgical pathology texts but lack a dedicated skin volume. With rising melanoma incidence pushing more biopsy volume through training programs, this is a reasonable moment to check whether the 6th Edition has replaced the 5th on the shelf.
CLNZ Books ships this title worldwide, with secure payment by card or PayPal and institutional invoicing available on request — our acquisitions team is glad to help with quotes, purchase orders, or standing-order arrangements for libraries and departments.
Q&A
Q: What does the 6th edition of McKee's Pathology of the Skin add for melanoma diagnosis specifically?
A: A fully revised melanoma chapter reflecting recent advances in cancer research, molecular mechanisms of disease, and the implications of those mechanisms for targeted therapy — directly relevant as melanoma incidence and molecular staging tools both keep evolving.
Q: Is McKee's Pathology of the Skin useful for general surgical pathologists, not just dermatopathology specialists?
A: Yes — it's written as a must-have resource for practicing dermatopathologists and for general pathologists who sign out skin biopsies as part of a broader caseload.
Q: Does this reference cover molecular and genomic testing relevant to current melanoma staging?
A: It includes updated content on next-generation sequencing and other molecular assays, along with new antigens and antibodies used for tumor diagnosis and staging.
Q: Is McKee's Pathology of the Skin a good fit for an academic medical library's core pathology collection?
A: Yes — it's the long-standing benchmark dermatopathology reference and a natural complement to general surgical pathology holdings, with an eBook included for shared digital access.
Q: Where can I buy McKee's Pathology of the Skin with Clinical Correlations (2 Volume Set), 6th Edition?
A: Directly from CLNZ Books, with worldwide shipping and secure payment by card or PayPal.